OUR MISSION

The PHARE Study group seeks to: 

1)    Describe burden of illness and understand factors that drive
       the use of medications and health care services in vulnerable
       populations;

2)    Conduct rigorous pharmacoepidemiologic research to
       advance understanding of beneficial and adverse effects
       of medications in populations systematically excluded from
       clinical trials;

 3)    Develop novel approaches leveraging large administrative data sources to understand the heterogeneity of
        treatment effects in clinically complex patients;

 4)    Evaluate the extent to which advanced statistical methods reduce the impact of selection bias, confounding,
        misclassification and missing data;

 5)    Translate and disseminate research findings to inform health care policy and practice, and

 6)    Educate, train, and mentor current and future scientists.